Commonwealth Bank of Australia’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-20,010
Closed -$2.03M 275
2019
Q2
$2.03M Buy
20,010
+428
+2% +$41.1K 0.02% 398
2019
Q1
$1.75M Buy
19,582
+59
+0.3% +$5.11K 0.02% 436
2018
Q4
$1.62M Buy
19,523
+262
+1% +$24.6K 0.02% 426
2018
Q3
$2.07M Sell
19,261
-200
-1% -$21.9K 0.02% 397
2018
Q2
$2.13M Sell
19,461
-1,251
-6% -$130K 0.02% 367
2018
Q1
$2.07M Sell
20,712
-3,972
-16% -$407K 0.02% 353
2017
Q4
$2.42M Sell
24,684
-311
-1% -$29.5K 0.02% 348
2017
Q3
$2.33M Buy
24,995
+2,391
+11% +$254K 0.02% 352
2017
Q2
$2.51M Buy
22,604
+1,398
+7% +$148K 0.03% 330
2017
Q1
$2.08M Sell
21,206
-5,773
-21% -$550K 0.02% 348
2016
Q4
$2.48M Buy
26,979
+2,056
+8% +$177K 0.03% 312
2016
Q3
$2.11M Sell
24,923
-200
-0.8% -$16.8K 0.03% 319
2016
Q2
$2.05M Sell
25,123
-814
-3% -$62K 0.02% 321
2016
Q1
$1.85M Buy
25,937
+2,053
+9% +$138K 0.02% 336
2015
Q4
$1.7M Sell
23,884
-2,649
-10% -$178K 0.02% 348
2015
Q3
$1.63M Buy
26,533
+500
+2% +$34.9K 0.02% 365
2015
Q2
$1.89M Sell
26,033
-100
-0.4% -$7.38K 0.03% 303
2015
Q1
$2.01M Sell
26,133
-600
-2% -$43K 0.03% 297
2014
Q4
$1.79M Buy
26,733
+1,565
+6% +$98.8K 0.03% 308
2014
Q3
$1.53M Buy
25,168
+1,400
+6% +$86.3K 0.02% 379
2014
Q2
$1.4M Sell
23,768
-10,845
-31% -$635K 0.02% 402
2014
Q1
$2M Buy
34,613
+1,000
+3% +$53.6K 0.01% 668
2013
Q4
$1.8M Buy
33,613
+2,833
+9% +$168K 0.01% 653
2013
Q3
$1.9M Buy
30,780
+2,049
+7% +$123K 0.01% 604
2013
Q2
$1.74M Buy
+28,731
New +$1.71M 0.01% 601

Other funds holding DGX

Commonwealth Bank of Australia's DGX Position: Q3 2019 in Review

Commonwealth Bank of Australia sold out of Quest Diagnostics (DGX) in Q3 2019, closing a stake of 20,010 shares — an estimated $2.03M sold.

Commonwealth Bank of Australia first reported a position in DGX in Q2 2013 and held it in 25 quarters. The position peaked at $2.51M in Q2 2017. 677 funds tracked by Wall St. Rank hold DGX as of Q3 2019.

  • Commonwealth Bank of Australia reported no remaining Quest Diagnostics position as of Q3 2019 after selling out during the quarter.
  • Commonwealth Bank of Australia sold 20,010 Quest Diagnostics shares in Q3 2019, an estimated $2.03M.
  • Commonwealth Bank of Australia first reported a position in Quest Diagnostics in Q2 2013 and held it in 25 quarters.
  • Commonwealth Bank of Australia's Quest Diagnostics position peaked at $2.51M in Q2 2017.
  • 677 funds tracked by Wall St. Rank held Quest Diagnostics as of Q3 2019.

Based on Commonwealth Bank of Australia's 13F filing for Q3 2019.